Wizard Biotech Pvt. Ltd. - Due diligence report

A 360° intelligence report on Wizard Biotech Pvt. Ltd.: trust score, financial health, credit view, compliance, directors, growth and distre…

2000-09-11 Kota, Rajasthan Active Unlisted Active Non-Compliant
Share
WB Wizard Biotech Pvt. Ltd.
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Wizard Biotech Pvt. Ltd. — 360° Intelligence Report

Generated from MCA filings & public records
36/100
Trust Score
Caution Indicated

Wizard Biotech Pvt. Ltd. is assessed as Caution Indicated with a Trust Score of 36/100. Wizard Biotech Pvt. Ltd. is an active private limited indian non-government company incorporated in 2000, operating in the Life Sciences sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 21 Jul 2026 from the latest processed filings. Wizard Biotech Pvt. Ltd. snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
36/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
5/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 4 open (6.50 cr) · 1 satisfied (36.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Axis Bank Limited1 48.0 cr
Hdfc Bank Limited1 48.0 cr
United Western Bank Ltd.2 48.0 cr
Oriental Bank Of Commerce1 48.0 cr
Compliance Score: 5/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2017 - filings overdue.
  • Flagged by authority: BANKS, MCA.
  • Litigation present in 3 court forum(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
BAIJNATH SHIVSHANKAR BAJPAI 01234567 Director 01/04/2018 6 yrs Approved
RAJEEV BAIJNATH BAJPAI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • BAIJNATH SHIVSHANKAR BAJPAI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: RAJEEV BAIJNATH BAJPAI (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 60
Growth signals & trust indicators
Operating for 25+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
Negative net worth.
Statutory filings appear overdue.
Compliance score is weak (5/100).
4 open charge(s) registered - assets are encumbered.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence31/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment22/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 4 open charge(s) of 6.50 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view28/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 14 events
30 Sep 2017
Last AGM held
Annual general meeting
19 Jun 2017
Securities allotted
250000 Equity Shares Without Differential Rights - 25.00 Lakh raised
31 Mar 2017
Latest balance sheet
Filed with ROC
31 Mar 2009
Securities allotted
250000 Equity Shares Without Differential Rights - 25.00 Lakh raised
26 Aug 2008
Charge created
Axis Bank Limited - 5.25 cr
16 Jul 2008
Director ceased
RICHA RAJEEV BAJPAI
25 Oct 2007
Charge satisfied
United Western Bank Ltd.
18 Jun 2007
Charge created
Hdfc Bank Limited - 85.00 Lakh
07 Jun 2004
Charge created
United Western Bank Ltd. - 32.00 Lakh
28 Jan 2003
Charge created
United Western Bank Ltd. - 36.00 Lakh
08 Aug 2001
Charge created
Oriental Bank Of Commerce - 8.00 Lakh
16 May 2001
Director appointed
BAIJNATH SHIVSHANKAR BAJPAI (Director)
11 Sep 2000
Incorporated
Registered with Roc Jaipur
Director appointed
RAJEEV BAIJNATH BAJPAI (Managing Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 3 financial year(s).
2 active director(s) / partner(s); review board churn before relying on management continuity.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
Peer companies will appear here as our matching engine processes this industry.
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Wizard Biotech Pvt. Ltd. before audits and certifications: compliance score 5/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Wizard Biotech Pvt. Ltd.: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Wizard Biotech Pvt. Ltd. - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 36/100, distress signals and MSME payment-delay disclosures - know whether Wizard Biotech Pvt. Ltd. pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Wizard Biotech Pvt. Ltd. - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Wizard Biotech Pvt. Ltd. an active company?

Wizard Biotech Pvt. Ltd. has MCA status “Active” with a compliance score of 5/100 (Caution Indicated).

Is Wizard Biotech Pvt. Ltd. financially healthy?

Wizard Biotech Pvt. Ltd. has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Wizard Biotech Pvt. Ltd.?

Its overall Trust Score is 36/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Wizard Biotech Pvt. Ltd.?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Wizard Biotech Pvt. Ltd. have loans or charges against its assets?

4 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Wizard Biotech Pvt. Ltd. up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 5/100 (Caution Indicated).

Is it risky to lend to Wizard Biotech Pvt. Ltd.?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.